Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Risk Anal ; 41(4): 661-677, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33368456

RESUMEN

Diesel vehicles are significant contributors to air pollution in Mexico City. We estimate the costs and mortality benefits of retrofitting heavy-duty vehicles with particulate filters and oxidation catalysts. The feasibility and cost-effectiveness of controls differ by vehicle model-year and type. We evaluate 1985 to 2014 model-year vehicles from 10 vehicle classes and five model-year groups. Our analysis shows that retrofitting all vehicles with the control that maximizes expected net benefits for that vehicle type and model-year group has the potential to reduce emissions of primary fine particles (PM2.5 ) by 950 metric tons/year; cut the population-weighted annual mean concentration of PM2.5 in Mexico City by 0.90 µg/m3 ; reduce the annual number of deaths attributable to air pollution by over 80; and generate expected annual health benefits of close to 250 million US$. These benefits outweigh expected costs of 92 million US$ per year. Diesel retrofits are but one step that should viewed in the context of other efforts--such as development of an integrated public transportation system, promotion of the rational use of cars, reduction of emissions from industrial sources and fires, and redesign of the Mexico City Metropolitan Area to reduce urban sprawl--that must be analyzed and implemented to substantially control air pollution and protect public health. Even if considering other potential public health interventions, which would offer greater benefits at the same or lower costs, only by conducting, promoting, and publishing this sort of analyses, we can make strides to improve public health cost-effectively.


Asunto(s)
Contaminantes Atmosféricos/análisis , Contaminación del Aire/análisis , Material Particulado/análisis , Emisiones de Vehículos/análisis , Ciudades , Monitoreo del Ambiente , Costos de la Atención en Salud , Humanos , México , Modelos Económicos , Salud Pública , Transportes
2.
Respir Res ; 14: 14, 2013 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-23379631

RESUMEN

BACKGROUND: We previously reported that asthmatic children with GSTM1 null genotype may be more susceptible to the acute effect of ozone on the small airways and might benefit from antioxidant supplementation. This study aims to assess the acute effect of ozone on lung function (FEF(25-75)) in asthmatic children according to dietary intake of vitamin C and the number of putative risk alleles in three antioxidant genes: GSTM1, GSTP1 (rs1695), and NQO1 (rs1800566). METHODS: 257 asthmatic children from two cohort studies conducted in Mexico City were included. Stratified linear mixed models with random intercepts and random slopes on ozone were used. Potential confounding by ethnicity was assessed. Analyses were conducted under single gene and genotype score approaches. RESULTS: The change in FEF(25-75) per interquartile range (60 ppb) of ozone in persistent asthmatic children with low vitamin C intake and GSTM1 null was -91.2 ml/s (p = 0.06). Persistent asthmatic children with 4 to 6 risk alleles and low vitamin C intake showed an average decrement in FEF(25-75) of 97.2 ml/s per 60 ppb of ozone (p = 0.03). In contrast in children with 1 to 3 risk alleles, acute effects of ozone on FEF25-75 did not differ by vitamin C intake. CONCLUSIONS: Our results provide further evidence that asthmatic children predicted to have compromised antioxidant defense by virtue of genetic susceptibility combined with deficient antioxidant intake may be at increased risk of adverse effects of ozone on pulmonary function.


Asunto(s)
Antioxidantes/administración & dosificación , Ácido Ascórbico/administración & dosificación , Asma/genética , Suplementos Dietéticos , Exposición a Riesgos Ambientales/efectos adversos , Enzimas/genética , Interacción Gen-Ambiente , Predisposición Genética a la Enfermedad , Ozono/efectos adversos , Factores de Edad , Deficiencia de Ácido Ascórbico/tratamiento farmacológico , Deficiencia de Ácido Ascórbico/epidemiología , Asma/diagnóstico , Asma/enzimología , Asma/epidemiología , Asma/fisiopatología , Asma/prevención & control , Niño , Estudios de Cohortes , Método Doble Ciego , Femenino , Gutatión-S-Transferasa pi/genética , Glutatión Transferasa/genética , Humanos , Modelos Lineales , Pulmón/fisiopatología , Masculino , Flujo Espiratorio Medio Máximo , México/epidemiología , NAD(P)H Deshidrogenasa (Quinona)/genética , Fenotipo , Polimorfismo Genético , Medición de Riesgo , Factores de Riesgo , Salud Urbana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA